退市！又一A股公司摘牌，涉近3万股东

Core Points - *ST Jiyao's stock will be delisted on May 29, 2025, without entering a delisting adjustment period due to triggering mandatory delisting conditions [2][4] - The company has appointed Shanxi Securities Co., Ltd. as its main sponsor to assist with the transfer of shares and related matters following the delisting [4] Financial Performance - As of March 31, 2025, *ST Jiyao had 28,056 shareholders, and its stock was suspended from trading on April 24, 2025, with a closing price of 0.21 yuan per share before suspension [5] - On the last trading day before suspension, the stock opened at a limit-down price of 0.19 yuan, briefly rising to 0.23 yuan, with a turnover rate of 29.42% and a total trading volume of nearly 40 million yuan [6] - The company reported a revenue of 333.33 million yuan for 2024, a decrease of 3.69% year-on-year, and a net loss of 439.43 million yuan, compared to a loss of 349.31 million yuan in the previous year [8][9] - For Q1 2025, the company achieved a revenue of 6.37 million yuan, down 15.53% year-on-year, with a net loss of 45.17 million yuan, compared to a loss of 40.85 million yuan in the same period last year [10] Company Background - *ST Jiyao, officially known as Jiyao Holding Group Co., Ltd., was established in 2000 and operates in the pharmaceutical industry, including manufacturing, wholesale, retail, and healthcare services [8] - The company transitioned from a chemical business to pharmaceuticals in 2014 and has faced continuous losses since 2019 [8]